Year: 2012
Type: preprint
Abstract: Glioblastoma is both the most common and lethal primary malignant brain tumor. Extensive multiplatform genomic characterization has provided a higher-resolution picture of the molecular alterations underlying this disease. These studies provide the emerging view that "glioblastoma" represents several histologically similar yet molecularly heterogeneous diseases, which influences taxonomic classification systems, prognosis, and therapeutic decisions.
Source: Genes & Development
Institutions: Broad Institute, Harvard University, Massachusetts General Hospital, Dana-Farber Cancer Institute, Dana-Farber/Harvard Cancer Center, Center for Neuro-Oncology, University of California San Diego, Brigham and Women's Hospital, Memorial Sloan Kettering Cancer Center, Heidelberg University, The University of Texas MD Anderson Cancer Center
Language: English
Subfield: Genetics
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
Awards: Mechanisms of Glioma Resistance to EGFR Inhibition, Therapeutic Opportunities for Pediatric Astrocytoma, G1864703947, G2757605240, G3146183854, G3305534244, G3746145884, G4612228525, G6247146851, G6671539959, Characterization of GEFT AS a Novel Glioblastoma Oncogene, G9000061708, Genetics and Biology of Pancreatic Ductal Adenocarcinoma
OpenAlex ID: W2166798417
